Baird Medical posts restated audited 2025 net loss of US$27.54 million
BDMD•Restated audited annual results
Baird Medical Investment Holdings filed an audited restatement of its annual results for the year ended Dec. 31, 2025.
- Net loss was USD 27.54 million, versus net income of USD 12.6 million a year earlier; revenue fell to USD 22.54 million from USD 37.04 million.
- Operating loss was USD 25.63 million, versus operating income of USD 15.32 million; operating expenses rose to USD 44.51 million from USD 17.34 million.
- Cash was USD 178,321, restricted cash was USD 387,496; short-term bank loans were USD 10.43 million at year-end.
- Accounts receivable, net was USD 42.53 million; allowance for expected credit losses was USD 4.76 million.
